Leistungsverzeichnis
Alphabetischer Schnellzugriff
A | B-D | E-G | H-L | M | N-R | S | T-Z
A
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Abstammungsuntersuchung |
--- | PCR | EDTA-Blut | 3 ml | 8-10 Tage |
| Mundschleimhautab. | 1x pro Person | ||||
| Acetylcholinesterase (ACHE)* | 100740 | Proteingelelektrophorese | natives Fruchtw. | 1 ml | 3 Tage |
| Achondroplasie |
100800 | Seq | EDTA-Blut | 3 ml | 3-5 Tage |
| Adrenogenitales SyndromCO | 201910 | Seq, Southern | EDTA-Blut | 3 ml | 4-6 Wochen |
| Alpha-1-Antitrypsin-Mangel (PiS,PiZ,PiM) | 107400 | Seq | EDTA-Blut | 3 ml | 3-5 Tage |
| Alphafetoprotein (AFP)CO | 104150 | ELISA | natives Fruchtw. | 1 ml | 3 Tage |
| Amyotrophe Lateralsklerose (fam. Form)CO | 105400 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Andersen-Tawil-Syndrom* | 170390 | PCR, Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Angelman-like XLMR (SLC9A6)* |
300243 |
Seq |
EDTA-Blut |
3 ml |
2-4 Wochen |
| Angelman-Syndrom (AS) |
105830 | FISH | Chromosomenpräparat | 1-2 Präp. | 3-5 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 3-5 Tage | ||
| PCR (Methylierungstest) | EDTA-Blut | 3 ml | 2 Wochen | ||
| Angelman-Syndrom (UBE3A-Mutation) |
105830 |
Seq |
EDTA-Blut |
3 ml |
2-4 Wochen |
| Array-CGH (Gen-Chip) | EDTA-Blut | 2-3 ml | 2-3 Wochen | ||
| Gewebe | 100 mg | 2-3 Wochen | |||
| Azoospermiefaktor | 415000 | PCR | EDTA-Blut | 3 ml | 3-5 Tage |
B-D
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Brustkrebs (BRCA1, BRCA2) | 114480 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Carnithin-Palmitoyl-Transferase-II-Mangel(CPT II)* |
600650 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Caveolinopathie* | 601253 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Central-Core-Myopathie (RYR1)* |
117000 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Chorea Huntington |
143100 | PCR | EDTA-Blut | 3 ml | 2 Wochen |
| Charcot-Marie-Tooth 1A (PMP22-Gen) | 118220 | PCR,Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Charcot-Marie-Tooth 1B (MPZ-Gen) | 118200 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Charcot-Marie-Tooth 1D* (EGR2-Gen) | 607678 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Charcot-Marie-Tooth 1X (GJB1-Gen) | 302800 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Charcot-Marie-Tooth 2A (MFN2-Gen) | 609260 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Charcot-Marie-Tooth 4A (GDAP1-Gen) | 214400 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Coffin-Lowry-Syndrom* |
303600 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Connexin 26 (Schwerhörigkeit) |
220290 | PCR, Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Cornelia-de-Lange-Syndrom | 122470 | Seq | EDTA-Blut | 3 ml | 4-8 Wochen |
| Chromosomenaberrationen |
--- | Standard Chromosomenanalyse (GTG-Banden) |
Fruchtwasser | 10-15 ml | 10-14 Tage |
| Chorionzotten | 15-25 mg | 1-2 / 10-14 Tage | |||
| Gewebe | ca. 100 mg | 14-21 Tage | |||
| Heparin Blut | 3 ml | 3-10 Tage | |||
| Nabelschnurblut | 1-2 ml | 3-4 Tage | |||
| Congenitale bilaterale Aplasie des Vas Deferens (CBAVD) |
277180 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Seq | EDTA-Blut | 3 ml | 2-4 Wochen | ||
| Craniosynostosen (Apert, Crouzon, u.a.) | 101200, 123500 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Cri-du-chat-Syndrom (5p-) |
123450 | FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| MLPA |
EDTA-Blut | 3 ml | 7-10 Tage | ||
| Crigler-Najjar-Syndrom* | 218800 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Cystische Fibrose (Mukoviszidose) |
219700 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Seq | EDTA-Blut | 3 ml | 2-4 Wochen | ||
| Cytochrom P450-Familie (CYP2C9, CYP2C19, CYP2D6) |
601130, 124020, 124030 | PCR | EDTA-Blut | 3 ml | 4-8 Wochen |
| de-Grouchy-Syndrom (18p-) |
607500 | Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 7-10 Tage |
| DiGeorge-Syndrom (CATCH22) |
188400 | FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| MLPA oder array-CGH | EDTA-Blut | 3 ml | 7-10 Tage | ||
| DNA-Asservierung | --- | |
EDTA-Blut | 3 ml | |
| Dravet-Syndrom | 607208 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
E-G
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Emery-Dreifuss-Muskeldystrophie (LMNA)* |
310300 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Epilepsie, pyridoxin-abhängig |
266100 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Epilepsie (SMEI, schwere myoklone infantile Epilepsie) |
607208 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Episodische Ataxie Typ I* | 108500 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Episodische Ataxie Typ II* | 160120 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Duchennesche/ Beckersche Muskeldystrophie |
310200, 300376 | PCR | EDTA-Blut | 3 ml | 2-4 Wochen |
| Faktor-II-Mutation, 20210G>A (Prothrombin-Mutation) |
176930 | PCR | EDTA-Blut | 3 ml | 3-5 Tage |
| Faktor-V-Leiden-Mutation 1691>A (APC-Resistenz) |
227400 | PCR | EDTA-Blut | 3 ml | 3-5 Tage |
| Familiäre adenomatöse Polyposis (FAP)CO | 175100 | Seq | EDTA-Blut | 3 ml | mehrere Wochen |
| Familiäre hemiplegische Migräne (FHM1-3)* |
141500, 602481, 609634 |
Seq |
EDTA-Blut |
3 ml |
4 Wochen |
| Familiäres Mittelmeerfieber (FMF)SD | 249100 | Seq | EDTA-Blut | 3 ml | ca. 2 Wochen |
| Familiäres nicht-polypöses Kolonkarzinom (HNPCC)CO | 114500 | PCR, Seq | Tumorgewebe, EDTA-Blut | Block, 3 ml | mehrere Wochen |
| Fra(X)-Syndrom Typ A |
309550, 300624 |
Southern, PCR | EDTA-Blut | 5 ml | 1-2 Wochen |
| Friedreich-AtaxieCO | 229300 | PCR | EDTA-Blut | 3 ml | 2-4 Wochen |
| GEFS, generalisierte Epilepsien | 604233 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Glukose-Transporter-Defizienz* | 138140 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Glykogenose Typ 0 (GYS2) |
240600 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Glykogenose Typ I (von Gierke)* | 232200 |
Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| 232300 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen | |
| Glykogenose Typ III (Cori Forbes)* | 232400 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Glykogenose Typ V (McArdle) | 232600 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
H-L
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Hämochromatose (HH) | 235200 | PCR | EDTA-Blut | 3 ml | 2-4 Wochen |
| Hereditäre motorisch-sensor. Neuropathie (HMSN, CMT)SD(siehe Charcot-Marie-Tooth) | 302800, 118220 | PCR, Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Hereditäre Neuropathie mit Druckläsionen (HNPP) | 162500 | PCR, Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Hereditäres nicht-polypöses kolorektales Karzinom (HNPCC, Lynch-Syndrom)CO | 120435 | Mikrosatellitenanalyse, Seq |
EDTA-Blut | 3 ml | mehrere Wochen |
| Hereditäre Schwerhörigkeit, nicht-syndromale (DFNB1, DFNA3) |
220290, 601544 |
Seq | EDTA-Blut | 3 ml |
2-4 Wochen |
| Hereditäre Spinalparaparese (SPG4)* | 182601 |
Seq |
EDTA-Blut | 3 ml |
4 Wochen |
| Heterotaxie-Syndrom (ZIC3, CFC1, NODAL)* |
300265 |
Seq |
EDTA-Blut | 3 ml |
2-4 Wochen |
| Hypochondroplasie (HCH) |
146000 | Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Hyper-/Hypokaliämische periodische Paralyse (HypoPP, HyperPP) |
170500, 170400 |
Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Kallmann-Syndrom |
147950, 308700, 244200, 610628 |
FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| MLPA | EDTA-Blut | 3 ml | 7-10 Tage | ||
| Klinefelter-Syndrom |
278850 |
Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 5-7 Tage |
| Langer-Giedion-Syndrom* | 150230 | MLPA oder array-CGH | EDTA-Blut | 3 ml | 2 Wochen |
| Lissencephalie* (siehe Miller-Dieker-Syndrom) |
607432 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Leukoenzephalopathie (EIF2)* | 603896 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Lujan-Fryns-Syndrom* |
309520 |
Seq |
EDTA-Blut | 3 ml |
1 Woche |
M
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Maligne Hyperthermie* | 145600 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Marfan-SyndromCO | 154700 | Seq | EDTA-Blut | 3 ml | mehrere Wochen |
| Methylentetrahydrofolatreduktase (MTHFR, C677T) | 607093 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Mikrodeletion 1p36 |
607872 | Chromosomenanalyse + FISH | Heparin Blut | 3 ml | 5-7 Tage |
| Miller-Dieker-Syndrom |
247200 | FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3 ml | 7-10 Tage | ||
| Morbus Fabry | 301500 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Morbus Meulengracht (Gilbert-Syndrom) | 143500 | Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Morbus Crouzon | 123500 | Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Morbus Wilson* | 277900 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| MTHFR-Polymorphismus | 607093 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Muskeldystrophie Typ Duchenne |
300376 | PCR | EDTA-Blut | 3 ml | 2-4 Wochen |
| Muskeldystrophie Typ Becker-Kiener |
300376 | PCR | EDTA-Blut | 3 ml | 2-4 Wochen |
| Myotone Dystrophie (DM1, Curshmann-Steinert) |
160900 | Southern, PCR | EDTA-Blut | 5 ml | 2-3 Wochen |
| Myotonia congenita (Typ Thomsen) | 160800 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Myotonia congenita (Typ Becker) | 255700 | Seq | EDTA-Blut | 3 ml | 2 Wochen |
| Myotonia Potassium-Aggravated (PAM) | 608390 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Neurofibromatose Typ1/ Typ2 |
162200, 101000 | Seq | EDTA-Blut | 3 ml | mehrere Wochen |
N-R
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Noonan-Syndrom |
163950 | PCR, Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Osteogenesis imperfecta | 166200 | Seq | EDTA-Blut | 3 ml | mehrere Wochen |
| Paramyotonia congenita (Typ Eulenburg) | 168300 | PCR, Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Paradontosekeime |
--- | PCR | Sulkusabstrich | 1-5 Papier- spitzen |
2-5 Tage |
| Pelizaeus-Merzbacher-Syndrom (GJA12)* |
312080 |
Seq |
EDTA-Blut |
3 ml |
2-4 Wochen |
| Pendred-Syndrom (Schwerhörigkeit) | 274600 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Pharmakogenetik (Cytochrom-P450-Enzyme 2D6, 2C19, 2C9) |
124030 | PCR | EDTA-Blut | 3 ml | 4-8 Wochen |
| Phelan-McDermid-Syndrom (Monosomie 22q13) | 606232 | MLPA oder array-CGH | EDTA-Blut | 3 ml | 2 Wochen |
| Chromosomenanalyse + FISH | Heparin Blut | 2 ml | 2 Wochen | ||
| PPM-X (X-gebundene mentale Retardierung mit Makroorchidie)* | 300055 | Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Prader-Willi-Syndrom |
176270 | PCR (Methylierungstest) | EDTA-Blut + Heparin Blut | je 3 ml | 2-3 Wochen |
| 182279 | FISH | 7-10 Tage | |||
| Proximale myotone Myopathie (PROMM/DM2)CO | 602668 | PCR und Southern-Blot | EDTA-Blut | 3 ml | 2-4 Wochen |
| PTEN Hamartome tumor Syndrome (Cowden, BRRS, Proteus-Syndrom)* | 601728 |
Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Rett-Syndrom | 312750 | PCR, Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Rett-like-Syndrom(CDKL5/STK9)* |
300203 |
Seq |
EDTA-Blut | 3 ml |
4 Wochen |
| Rhesusinkompatibilität* (RhD/RhE/RhC) | 111700 | PCR | EDTA-Blut / Fruchtwasser | 3 ml | 2-3 Tage |
| Rubinstein-Taybi-Syndrom* (RTS) | 180849 | MLPA oder array-CGH |
EDTA-Blut | 3 ml | 2 Wochen |
S
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| SHOX | 312865 | PCR, Seq | EDTA-Blut | 3 ml | 4 Wochen |
| Smith-Lemli-Opitz-Syndrom | 270400 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Smith-Magenis-Syndrom |
182290 | Chromosomenanalyse + FISH | Heparin Blut | 3 ml | 5-7 Tage |
| Sotos-Syndrom | 117550 | Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Spinale Muskelatrophie (Typ I, II, III) |
253300 | PCR | EDTA-Blut | 3 ml | 2 Wochen |
| Spinale Muskelathrophie mit Atemnot SMARD1 (IGHMBP2) |
604320 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
| Spinobulbäre Muskelatrophie (Kennedy-Syndrom) |
313200 | Seq | EDTA-Blut | 3 ml | 5-7 Tage |
| Spinocerebelläre Ataxien (Typ 1,2,3,6)CO | 164400 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Subtelomer-FISH an Chromosomen |
--- | Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 5-7 Tage |
T-Z
| Untersuchung | OMIM | Technik | Material | Menge | Dauer |
| Telomer-FISH |
--- | FISH | Chromosomenpräparat | 3-5 Präp. | 2-3 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 7-10 Tage | ||
| Thalassämie (Beta-)CO | 604131, 141900 |
Seq | EDTA-Blut | 3 ml | 2-4 Wochen |
| Thanatophore Dysplasie (TD) |
187600, 187601 |
Seq | EDTA-Blut | 3 ml | 2-3 Wochen |
| Thrombophilie (Faktor II, Faktor V) |
176930, 227400 | PCR | EDTA-Blut | 3 ml | 5-7 Tage |
| Trisomie 13, 18, 21 |
190685 | FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 3-5 Tage | ||
| Ullrich-Turner-Syndrom |
--- | FISH | Chromosomenpräparat | 1-2 Präp. | 2-3 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 7-10 Tage | ||
| Uniparentale Disomien | --- | PCR | EDTA-Blut | 2 ml | 3-5 Tage |
| Wilms Tumor* |
194070 |
Seq |
EDTA-Blut | 3 ml |
2 Wochen |
| Williams-Beuren-Syndrom |
194050 | FISH | Chromosomenpräparat | 1-2 Präp. | 7-10 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 3-5 Tage | ||
| Wolf-Hirschhorn-Syndrom |
194190 | FISH | Chromosomenpräparat | 1-2 Präp. | 7-10 Tage |
| Chromosomenanalyse + FISH | Heparin Blut | 3-5 ml | 3-5 Tage | ||
| X-chromosomale Myopathie mit posturaler Muskelathrophie (XMPMA, FHL1)* |
300696 |
Seq |
EDTA-Blut | 3 ml | 2-4 Wochen |
* = derzeit nicht akkreditierte Untersuchungen
CO = in Kooperation
SD = Stufendiagnostik
Aktualisiert 03.08.2009
